Crystal Lake, Illinois Clinical Trials

A listing of Crystal Lake, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Study to Explore the Efficacy and Safety of BIO89-100 in Subjects With Severe Hypertriglyceridemia

This study is designed to assess the efficacy, safety, and tolerability of different doses and dose regimens (QW or every 2 weeks [Q2W]), subcutaneous (SC) dosing of BIO89-100 compared to placebo in subjects with Severe Hypertriglyceridemia (SHTG).

Family Medicine Specialists, Inc.
 (9.3 away) Contact site
  • 0 views
  • 05 Jun, 2021
  • +39 other locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

cancer
vitamin d
metastasis
folfiri
liver metastasis
AMG Crystal Lake - Oncology
 (2.5 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

This is a global, randomized, controlled, open-label Phase 3 study designed to assess the long-term efficacy and safety of UGN-102 (mitomycin) for intravesical solution with or without () transurethral resection of bladder tumors (TURBT) versus TURBT alone for the treatment of patients with low grade intermediate risk non-muscle-invasive bladder cancer …

transurethral resection
cancer
transurethral bladder excision
mitomycin
EGFR
Comprehensive Urologic Care
 (8.7 away) Contact site
  • 0 views
  • 09 Jul, 2021
  • +124 other locations
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining (residual) basal-like triple-negative breast cancer following chemotherapy after surgery (neoadjuvant). Drugs used in chemotherapy, such as cisplatin, carboplatin and capecitabine, work in different ways to stop the …

lobular carcinoma
cancer
invasive cancer
erbb2
metastasis
AMG Crystal Lake - Oncology
 (2.5 away) Contact site
  • 508 views
  • 24 Jan, 2021
  • +702 other locations
A Randomized Double-Blind Parallel Group Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

Study STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

dihydroergotamine
acute treatment
headache
CIS Research
 (9.3 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +139 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

cancer
palbociclib
metastasis
palliative radiation therapy
dabrafenib
North Shore Oncology Hematology Associates-Crystal Lake
 (2.5 away) Contact site
  • 6087 views
  • 01 Aug, 2021
  • +1020 other locations
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

replacement therapy
testosterone topical
testosterone
serum testosterone
testosterone level
Midwest Endocrinology /ID# 202992
 (0.6 away) Contact site
  • 16844 views
  • 30 Jul, 2021
  • +485 other locations
BlueWind RENOVA iStim System for the Treatment of OAB

The OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.

Comprehensive Urologic Care
 (8.7 away) Contact site
  • 24 views
  • 23 Jun, 2021
  • +30 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

hepatitis b
insulin
metastasis
pembrolizumab
immunodeficiency
AMG Crystal Lake - Oncology
 (2.3 away) Contact site
  • 206 views
  • 01 Aug, 2021
  • +831 other locations
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

The purpose of this study is to evaluate the safety and efficacy of OMS721 in patients with IgA nephropathy. The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment.

glomerular filtration rate
immunoglobulins
immunoglobulin a
proteinuria
Omeros Investigational Site
 (55.7 away) Contact site
  • 243 views
  • 22 Jan, 2021
  • +28 other locations